Encyclopedia of Heart Diseases

2011 Edition
| Editors: M. Gabriel Khan

Altitude and Pulmonary Edema

Reference work entry
DOI: https://doi.org/10.1007/978-1-60761-219-3_5

Overview

High-altitude  pulmonary edema (HAPE) is a noncardiogenic pulmonary edema that may occur in previously healthy individuals within the first 2–5 days after rapid ascent above 3,000–4,000 m. Severe shortness of breath occurs due to accumulation of fluid in air sacs of the lungs, and may occur in young, healthy, susceptible adults who ascend rapidly to altitudes in excess of 2,500 m.

Higgins and colleagues provided a review, which summarized the physiology and clinical evidence regarding acute altitude exposure on the cardiopulmonary system, and made practical recommendations for patients with cardiovascular disease.

A major preventive is slow ascent:
  • For ascent >3,050 m (10,000 ft), ascent should be ≤305 m (1,000 ft) daily with a rest every 1,000 m (3,300 ft) (Higgins et al. 2010).

  • The first symptom is usually  dyspneaon exertion and a reduced exercise tolerance greater than expected for the altitude. A dry and annoying cough later becomes productive with bloodstained sputum....

This is a preview of subscription content, log in to check access.

Bibliography

References

  1. Bai C, She J, Goolaerts A et al (2010) Stress failure plays a major role in development of high-altitude pulmonary oedema in rats. Eur Respir J 35:584–591PubMedGoogle Scholar
  2. Bärtsch P (1999) High altitude pulmonary edema. Med Sci Sports Exerc 31:S23–S27PubMedGoogle Scholar
  3. Bartsch P, Gibbs JSR (2007) Effect of altitude on the heart and the lungs. Circulation 116:2191–2202PubMedGoogle Scholar
  4. Bärtsch P, Maggiorini M, Ritter M et al (1991) Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 325:1284–1289PubMedGoogle Scholar
  5. Busch T, Bärtsch P, Pappert D et al (2001) Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high altitude pulmonary edema. Am J Respir Crit Care Med 163:368–373PubMedGoogle Scholar
  6. Duplain H, Sartori C, Lepori M et al (2000) Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Resp Crit Care Med 162:221–224PubMedGoogle Scholar
  7. Eldridge MW, Podolsky A, Richardson RS et al (1996) Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema. J Appl Physiol 81:911–921PubMedGoogle Scholar
  8. Fischler M, Maggiorini M, Dorschner L et al (2009) Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med 180:346–352PubMedGoogle Scholar
  9. Higgins JP, Tuttle T, Higgins JA (2010) Altitude and the heart: is going high safe for your cardiac patient? Am Heart J 159:25–32PubMedGoogle Scholar
  10. Hopkins SR (2010) Stress failure and high-altitude pulmonary edema: mechanistic insights from physiology. Eur Respir J 35:470–472PubMedGoogle Scholar
  11. Luks AM, Swenson ER (2008) Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 133:744–755PubMedGoogle Scholar
  12. Maggiorini M, Brunner-La Rocca H-P, Peth S et al (2006) Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema. Ann Intern Med 145:497–506PubMedGoogle Scholar
  13. Mairbäurl H, Weymann J, Möhrlein A et al (2003) Nasal epithelium potential difference at high altitude (4, 559 m). Am J Respir Crit Care Med 167:862–867PubMedGoogle Scholar
  14. Oelz O, Ritter M, Jenni R et al (1989) Nifedipine for high altitude pulmonary oedema. Lancet 2:1241–1244PubMedGoogle Scholar
  15. Podrid PJ, Fuchs T, Candinas R (1990) Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 82:1103–1113Google Scholar
  16. Pugin J, Verghese G, Widmer M-C et al (1999) The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27:304–312PubMedGoogle Scholar
  17. Sartori C, Allemann Y, Duplain H et al (2002) Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 346:1631–1636PubMedGoogle Scholar
  18. Scherrer U, Vollenweider L, Delabays A et al (1996) Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 334:624–629PubMedGoogle Scholar
  19. Swenson ER, Maggiorini M, Mongovin S et al (2002) Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 287:2228–2235PubMedGoogle Scholar

Suggested Reading

  1. Schoene RB (2008) Illnesses at high altitude. Chest 134:402–416PubMedGoogle Scholar
  2. West JB, Mathieu-Costello O (1992) Stress failure of pulmonary capillaries: role in lung and heart disease. Lancet 340:762–767PubMedGoogle Scholar
  3. West JB, Colice GL, Lee YJ et al (1995) Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries. Eur Respir J 8:523–529. [Abstract]PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2011